small molecule

XYZAL ALLERGY 24HR

LEVOCETIRIZINE DIHYDROCHLORIDE

Loss of exclusivityOctober 2027latest FDA-listed patent expiry
CompanyCHATTEM INC DBA SANOFI CONSUMER HEALTHCARE

Drug detail

Brand nameXYZAL ALLERGY 24HR
Active ingredientLEVOCETIRIZINE DIHYDROCHLORIDE
Strength2.5MG/5ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2017
Marketing statusOTC

Listed patents

PatentExpiresType
8633194October 2027product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.